MicroRNAs as biomarkers for CNS disease

For many neurological diseases, the efficacy and outcome of treatment depend on early detection. Diagnosis is currently based on the detection of symptoms and neuroimaging abnormalities, which appear at relatively late stages in the pathogenesis. However, the underlying molecular responses to geneti...

Full description

Bibliographic Details
Main Authors: Pooja eRao, Eva eBenito, André eFischer
Format: Article
Language:English
Published: Frontiers Media S.A. 2013-11-01
Series:Frontiers in Molecular Neuroscience
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fnmol.2013.00039/full